EDGAR Filing Documents for 0001104659-23-106030

Form 8-K - Current report:

SEC Accession No. 0001104659-23-106030

Filing Date

2023-10-03

Accepted

2023-10-02 18:29:23

Documents

Period of Report

2023-09-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2327415d1_8k.htm iXBRL	8-K	33694
2	EXHIBIT 4.1	tm2327415d1_ex4-1.htm	EX-4.1	88054
3	EXHIBIT 4.2	tm2327415d1_ex4-2.htm	EX-4.2	88465
4	EXHIBIT 4.3	tm2327415d1_ex4-3.htm	EX-4.3	88753
5	EXHIBIT 5.1	tm2327415d1_ex5-1.htm	EX-5.1	16492
6	EXHIBIT 10.1	tm2327415d1_ex10-1.htm	EX-10.1	243050
7	EXHIBIT 99.1	tm2327415d1_ex99-1.htm	EX-99.1	13426
11	GRAPHIC	tm2327415d1_ex5-1img001.jpg	GRAPHIC	9180
	Complete submission text file	0001104659-23-106030.txt		908944

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	hepa-20230928.xsd	EX-101.SCH	3009
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	hepa-20230928_lab.xml	EX-101.LAB	34240
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	hepa-20230928_pre.xml	EX-101.PRE	22355
13	EXTRACTED XBRL INSTANCE DOCUMENT	tm2327415d1_8k_htm.xml	XML	3326

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837

Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000

Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)